0

Journal Articles

in Prostate Cancer
 41-60 of 102 Articles
The World in Medicine |  March 19, 2008
Prostate Cancer Genes
Joan Stephenson, PhD
JAMA. 2008;299(11):1252. doi:10.1001/jama.299.11.1252-b.
Original Contribution |  January 23, 2008 FREE
Androgen Suppression and Radiation vs Radiation Alone for Prostate Cancer:  A Randomized Trial
Anthony V. D’Amico, MD, PhD; Ming-Hui Chen, PhD; Andrew A. Renshaw, MD; et al.
JAMA. 2008;299(3):289-295. doi:10.1001/jama.299.3.289.
Original Contribution |  November 21, 2007 FREE
Obesity-Related Plasma Hemodilution and PSA Concentration Among Men With Prostate Cancer
Lionel L. Bañez, MD; Robert J. Hamilton, MD, MPH; Alan W. Partin, MD, PhD; et al.
JAMA. 2007;298(19):2275-2280. doi:10.1001/jama.298.19.2275.
Preliminary Communication |  October 03, 2007 FREE
PSA Failure Following Definitive Treatment of Prostate Cancer Having Biopsy Gleason Score 7 With Tertiary Grade 5
Abhijit A. Patel, MD, PhD; Ming-Hui Chen, PhD; Andrew A. Renshaw, MD; et al.
JAMA. 2007;298(13):1533-1538. doi:10.1001/jama.298.13.1533.
JAMA Patient Page |  October 03, 2007 FREE
Grading of Prostate Cancer
John L. Zeller, MD, PhD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2007;298(13):1596. doi:10.1001/jama.298.13.1596.
Editorial |  December 13, 2006
Treating Older Men With Prostate Cancer:  Survival (or Selection) of the Fittest?
Mark S. Litwin, MD, MPH; David C. Miller, MD, MPH
JAMA. 2006;296(22):2733-2734. doi:10.1001/jama.296.22.2733.
Original Contribution |  December 13, 2006 FREE
Survival Associated With Treatment vs Observation of Localized Prostate Cancer in Elderly Men
Yu-Ning Wong, MD; Nandita Mitra, PhD; Gary Hudes, MD; et al.
JAMA. 2006;296(22):2683-2693. doi:10.1001/jama.296.22.2683.
Editorial |  November 15, 2006
PSA Testing:  Public Policy or Private Penchant?
Peter C. Albertsen, MD, MS
JAMA. 2006;296(19):2371-2373. doi:10.1001/jama.296.19.2371.
Editorial |  November 15, 2006
Improving Men's Health:  Evidence and Opportunity
Phil B. Fontanarosa, MD, MBA; Helene M. Cole, MD
JAMA. 2006;296(19):2373-2375. doi:10.1001/jama.296.19.2373.
Medical News and Perspectives |  November 15, 2006
Researchers Probe Consequences of Androgen Deprivation for Prostate Cancer
JAMA. 2006;296(19):2301-2306. doi:10.1001/jama.296.19.2305.
Original Contribution |  November 15, 2006 FREE
Adjuvant Radiotherapy for Pathologically Advanced Prostate Cancer:  A Randomized Clinical Trial
Ian M. Thompson, MD; Catherine M. Tangen, DrPH; Jorge Paradelo, MD; et al.
JAMA. 2006;296(19):2329-2335. doi:10.1001/jama.296.19.2329.
Original Contribution |  November 15, 2006 FREE
PSA Screening Among Elderly Men With Limited Life Expectancies
Louise C. Walter, MD; Daniel Bertenthal, MPH; Karla Lindquist, MS; et al.
JAMA. 2006;296(19):2336-2342. doi:10.1001/jama.296.19.2336.
JAMA Patient Page |  November 15, 2006 FREE
Prostate Cancer
John L. Zeller, MD, PhD; Cassio Lynm, MA; Richard M. Glass, MD
JAMA. 2006;296(19):2402. doi:10.1001/jama.296.19.2402.
The World in Medicine |  June 21, 2006
Prostate Cancer Gene
JAMA. 2006;295(23):2711. doi:10.1001/jama.295.23.2711-a.
Medical News and Perspectives |  May 17, 2006
New Markers May Help Predict Prostate Cancer Relapse Risk
JAMA. 2006;295(19):2234-2238. doi:10.1001/jama.295.19.2234.
Medical News and Perspectives |  April 05, 2006
New Virus Linked to Prostate Cancer
JAMA. 2006;295(13):1503. doi:10.1001/jama.295.13.1503.
Medical News and Perspectives |  December 14, 2005
Gene Fusion Found in Prostate Cancer
JAMA. 2005;294(22):2832. doi:10.1001/jama.294.22.2832.
Editorial |  September 14, 2005
Radiation Dose Escalation as Treatment for Clinically Localized Prostate Cancer:  Is More Really Better?
Theodore L. DeWeese, MD; Danny Y. Song, MD
JAMA. 2005;294(10):1274-1276. doi:10.1001/jama.294.10.1274.
Original Contribution |  September 14, 2005 FREE
Comparison of Conventional-Dose vs High-Dose Conformal Radiation Therapy in Clinically Localized Adenocarcinoma of the Prostate:  A Randomized Controlled Trial
Anthony L. Zietman, MD; Michelle L. DeSilvio, PhD; Jerry D. Slater, MD; et al.
JAMA. 2005;294(10):1233-1239. doi:10.1001/jama.294.10.1233.
Editorial |  July 27, 2005
PSA Kinetics and Risk of Death From Prostate Cancer:  In Search of the Holy Grail of Surrogate End Points
Mitchell S. Anscher, MD
JAMA. 2005;294(4):493-494. doi:10.1001/jama.294.4.493.

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA Internal Medicine
Original Investigation  |  June 10, 2013
Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality
Erin L. Richman, ScD; Stacey A. Kenfield, ScD; Jorge E. Chavarro, MD, ScD; et al.
JAMA Internal Medicine
Invited Commentary  |  June 10, 2013
Dietary Fat and Reduced Prostate Cancer Mortality: Does the Type of Fat Matter?:  Comment on “Fat Intake After Diagnosis and Risk of Lethal Prostate Cancer and All-Cause Mortality”
Stephen J. Freedland, MD
JAMA Internal Medicine
Editorial  |  April 15, 2013
Can We Stop Ordering Prostate-Specific Antigen Screening Tests?
Mitchell H. Katz, MD
JAMA Internal Medicine
Original Investigation  |  April 15, 2013
Five-Year Downstream Outcomes Following Prostate-Specific Antigen Screening in Older Men
Louise C. Walter, MD; Kathy Z. Fung, MS; Katharine A. Kirby, MS; et al.
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems